| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 吡啶类(元) | 1,659,671.10 | 1,293,386.53 | 3,219,267.00 | 941,739.44 |
| 吡咯类(元) | 902,955.54 | 452,335.97 | 922,406.95 | 443,856.46 |
| 吡嗪类(元) | 24,931,154.51 | 14,887,779.30 | 31,750,376.29 | 15,043,311.76 |
| 呋喃类(元) | 1,669,794.91 | 815,632.62 | 3,385,979.66 | 624,493.67 |
| 含硫类(元) | 24,253,409.46 | 13,034,722.20 | 21,309,232.24 | 11,530,501.32 |
| 内酯类(元) | - | - | - | 129,765.98 |
| 噻吩类(元) | 310,105.84 | 161,012.04 | 540,665.07 | 154,680.50 |
| 噻唑类(元) | 28,153,883.06 | 13,781,446.85 | 32,284,442.67 | 15,020,646.15 |
| 烯醛类(元) | 9,958,296.59 | 5,081,054.46 | 7,589,201.96 | 2,962,838.37 |
| 销售原材料(元) | - | - | - | 71,681.42 |
| 原材料销售(元) | - | - | 71,681.42 | - |
| 内酯类及其他(元) | 581,296.90 | 248,189.90 | 512,240.82 | - |
| 营业成本(元) | ||||
| 吡啶类(元) | 1,544,629.81 | 1,259,289.59 | 2,858,972.16 | 901,350.16 |
| 吡咯类(元) | 639,828.94 | 310,277.99 | 660,741.90 | 322,687.76 |
| 吡嗪类(元) | 21,151,453.41 | 12,987,378.04 | 26,534,005.72 | 12,929,629.91 |
| 呋喃类(元) | 1,188,422.96 | 560,356.12 | 2,344,430.01 | 392,767.45 |
| 含硫类(元) | 11,168,431.81 | 5,575,533.92 | 8,218,402.19 | 4,149,213.74 |
| 内酯类(元) | - | - | - | 21,958.40 |
| 噻吩类(元) | 123,472.05 | 91,171.00 | 212,727.39 | 81,207.26 |
| 噻唑类(元) | 19,977,118.76 | 10,525,034.24 | 22,323,256.73 | 11,198,872.61 |
| 烯醛类(元) | 8,867,194.15 | 4,027,422.96 | 6,858,576.62 | 2,155,618.53 |
| 销售原材料(元) | - | - | - | 66,211.30 |
| 原材料销售(元) | - | - | 66,211.30 | - |
| 内酯类及其他(元) | 505,436.81 | 116,048.83 | 421,708.14 | - |
| 毛利(元) | ||||
| 吡啶类(元) | 115,041.29 | 34,096.94 | 360,294.84 | 40,389.28 |
| 吡咯类(元) | 263,126.60 | 142,057.98 | 261,665.05 | 121,168.70 |
| 吡嗪类(元) | 3,779,701.10 | 1,900,401.26 | 5,216,370.57 | 2,113,681.85 |
| 呋喃类(元) | 481,371.95 | 255,276.50 | 1,041,549.65 | 231,726.22 |
| 含硫类(元) | 13,084,977.65 | 7,459,188.28 | 13,090,830.05 | 7,381,287.58 |
| 内酯类(元) | - | - | - | 107,807.58 |
| 噻吩类(元) | 186,633.79 | 69,841.04 | 327,937.68 | 73,473.24 |
| 噻唑类(元) | 8,176,764.30 | 3,256,412.61 | 9,961,185.94 | 3,821,773.54 |
| 烯醛类(元) | 1,091,102.44 | 1,053,631.50 | 730,625.34 | 807,219.84 |
| 销售原材料(元) | - | - | - | 5,470.12 |
| 原材料销售(元) | - | - | 5,470.12 | - |
| 内酯类及其他(元) | 75,860.09 | 132,141.07 | 90,532.68 | - |
| 毛利率(%) | ||||
| 吡啶类(%) | 6.93 | 2.64 | 11.19 | 4.29 |
| 吡咯类(%) | 29.14 | 31.41 | 28.37 | 27.30 |
| 吡嗪类(%) | 15.16 | 12.76 | 16.43 | 14.05 |
| 呋喃类(%) | 28.83 | 31.30 | 30.76 | 37.11 |
| 含硫类(%) | 53.95 | 57.23 | 61.43 | 64.02 |
| 内酯类(%) | - | - | - | 83.08 |
| 噻吩类(%) | 60.18 | 43.38 | 60.65 | 47.50 |
| 噻唑类(%) | 29.04 | 23.63 | 30.85 | 25.44 |
| 烯醛类(%) | 10.96 | 20.74 | 9.63 | 27.24 |
| 销售原材料(%) | - | - | - | 7.63 |
| 原材料销售(%) | - | - | 7.63 | - |
| 内酯类及其他(%) | 13.05 | 53.24 | 17.67 | - |
| 收入构成(%) | ||||
| 吡啶类(%) | 1.80 | 2.60 | 3.17 | 2.01 |
| 吡咯类(%) | 0.98 | 0.91 | 0.91 | 0.95 |
| 吡嗪类(%) | 26.98 | 29.92 | 31.25 | 32.06 |
| 呋喃类(%) | 1.81 | 1.64 | 3.33 | 1.33 |
| 含硫类(%) | 26.24 | 26.20 | 20.98 | 24.57 |
| 内酯类(%) | - | - | - | 0.28 |
| 噻吩类(%) | 0.34 | 0.32 | 0.53 | 0.33 |
| 噻唑类(%) | 30.46 | 27.70 | 31.78 | 32.01 |
| 烯醛类(%) | 10.77 | 10.21 | 7.47 | 6.31 |
| 销售原材料(%) | - | - | - | 0.15 |
| 原材料销售(%) | 0.00 | - | 0.07 | - |
| 内酯类及其他(%) | 0.63 | 0.50 | 0.50 | - |
| 毛利构成(%) | ||||
| 吡啶类(%) | 0.42 | 0.24 | 1.16 | 0.27 |
| 吡咯类(%) | 0.97 | 0.99 | 0.84 | 0.82 |
| 吡嗪类(%) | 13.87 | 13.29 | 16.78 | 14.37 |
| 呋喃类(%) | 1.77 | 1.78 | 3.35 | 1.58 |
| 含硫类(%) | 48.01 | 52.15 | 42.11 | 50.20 |
| 内酯类(%) | - | - | - | 0.73 |
| 噻吩类(%) | 0.68 | 0.49 | 1.05 | 0.50 |
| 噻唑类(%) | 30.00 | 22.77 | 32.04 | 25.99 |
| 烯醛类(%) | 4.00 | 7.37 | 2.35 | 5.49 |
| 销售原材料(%) | - | - | - | 0.04 |
| 原材料销售(%) | 0.00 | - | 0.02 | - |
| 内酯类及其他(%) | 0.28 | 0.92 | 0.29 | - |